Tag Archives: slxp

Valeant Mulls Higher Salix Bid, But Don’t Expect $170

Valeant Pharmaceuticals (VRX) is reportedly mulling a higher bid for Salix Pharmaceuticals (SLXP) even as Valeant investor Bill Ackman said it won’t “overpay.” Valeant is considering raising its all-cash offer to above $160 a share, according to multiple reports citing sources. It was originally reported Friday afternoon by New York Times. Valeant plans weekend meetings to discuss the issue, with no specific figure cited. Valeant last month agreed

Valeant Mulls Higher Cash Offer For Salix: Report

Valeant Pharmaceuticals (VRX) is reportedly mulling a higher bid for Salix Pharmaceuticals (SLXP) even as Valeant investor Bill Ackman said it won’t “overpay.” Valeant is considering raising its all-cash offer to above $160 a share, sources told the New York Times, though a specific figure wasn’t cited. Valeant last month agreed to pay $158 a share for Salix in an all-cash deal worth $10 billion, or $14.5 billion including assumed debt. But on

Endo Cuts In, Tops Valeant Bid For Salix

Endo Pharmaceuticals bid $175 a share to snatch a distressed specialty drugmaker from Valeant Pharmaceuticals (VRX), the company announced Wednesday afternoon. Salix Pharmaceuticals (SLXP) had already agreed on Feb. 22 to be bought by Valeant for $158 a share, or $14.5 billion including debt. The stock had been trading in that range since then, but when word of Endo’s (ENDP) bid leaked out early in the afternoon, the stock jumped